This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200505-740OCv1 173/4/370    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, S.-H. Articles by Park, C.-S. Search for Related Content PubMed PubMed Citation Articles by Lee, S.-H. Articles by Park, C.-S.

Complement C3a and C4a Increased in Plasma of Patients with Aspirin-induced Asthma

Genome Research Center for Allergy and Respiratory Diseases, Soonchunhyang University Hospital, Bucheon; Department of Chemistry, Soonchunhyang University, Asan; and Yonsei Proteome Research Center, Seoul, Korea

Correspondence and requests for reprints should be addressed to Choon-Sik Park, M.D., Ph.D., Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Hospital, 1174, Jung-dong, Wonmi-gu, Bucheon-si, Gyeonggido 420-767, Republic of Korea. E-mail: mdcspark{at}unitel.co.kr

Rationale: Aspirin-induced asthma (AIA) is a distinct clinical syndrome that affects up to 10% of adults with asthma. Although eicosanoid metabolites appear to play an important role in AIA, the exact pathogenic mechanism for the syndrome remains obscure. In addition, the proposed mechanism fails to explain why aspirin does not cause bronchoconstriction in all individuals.

Objectives: We aimed to identify proteins that were differentially expressed in between AIA and aspirin-tolerant asthma (ATA) plasma.

Methods and Main Results: By using a proteomics approach, six proteins were found to be differentially expressed in plasma between patients with AIA and patients with ATA at baseline, and eight proteins were significantly up- or down-regulated after aspirin challenge in patients with AIA. These proteins, which were identified by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, can be classified into four groups: complement components, apolipoproteins, modified albumin, and unknown proteins. Among them, the complement component levels in plasma were validated by using ELISA. Plasma concentrations of C3a and C4a were higher in patients with AIA (n = 30) than in patients with ATA (n = 24). After the aspirin challenge, C3 decreased in both patients with AIA and those with ATA, but the C3a concentration increased in the AIA patient group (p = 0.019). Moreover, C3a and C4a levels and the ratios of C3a/C3 and C4a/C4 were correlated with the changes of FEV₁ values after aspirin challenge.

Conclusions: Aspirin intolerance may be related to alterations in the levels of complements, as well as those of lipoprotein and other proteins.

Key Words: aspirin-induced asthma • complement C3a and C4a • two-dimensional electrophoresis

This article has been cited by other articles:

				L Mastalerz, M Sanak, A Gawlewicz-Mroczka, A Gielicz, A Cmiel, and A Szczeklik Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity Thorax, January 1, 2008; 63(1): 27 - 34. [Abstract] [Full Text] [PDF]

				M. Wills-Karp Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma Proceedings of the ATS, July 1, 2007; 4(3): 247 - 251. [Abstract] [Full Text] [PDF]

				W. C. Moore and S. P. Peters Update in Asthma 2006 Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654. [Full Text] [PDF]